Extra shot tested to protect vulnerable transplant patients from COVID
NCT ID NCT05220397
Summary
This study tested if giving a dose of the Johnson & Johnson COVID-19 vaccine could improve immune protection in kidney transplant patients. These patients often have a weaker response to standard mRNA vaccines (like Pfizer or Moderna). The trial enrolled 468 kidney transplant recipients who had already received two or three mRNA vaccine doses but still had low antibody levels, aiming to see if the different vaccine could boost their immunity.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANT RECIPIENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic
Phoenix, Arizona, 85054, United States
-
Mayo Clinic
Jacksonville, Florida, 32224, United States
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
Conditions
Explore the condition pages connected to this study.